Login Register Cart 0
Generic placeholder image

Current Enzyme Inhibition

Editor-in-Chief

ISSN (Print): 1573-4080
ISSN (Online): 1875-6662

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

A Perspective of Viruses and the Outbreak of a Novel Coronavirus SARS-CoV- 2

Author(s): Satya P. Gupta *

Volume 16, Issue 2, 2020

Page: [107 - 114] Pages: 8

DOI: 10.2174/1573408016999200525155302

Price: $65

Abstract

The article presents some introductory remarks on viruses and in general how they lead to diseases. With reference to same, it discusses the emergence of a fairly novel coronavirus, 2019- CoV-2 and its possible medication.

Keywords: ACE, convalescent plasma, COVID-19, MERS-CoV, severe acquired respiratory syndrome corona viruses, viruses.

Next »
Graphical Abstract

[1]
Rybicki, E.P. The classification of organisms at the edge of life, or problems with virus systematics. S. Afr. J. Sci., 1990, 86, 182-186.
[2]
Koonin, E.V.; Starokadomskyy, P. Are viruses alive? The replicator paradigm sheds decisive light on an old but misguided question. Stud Hist Philos Biol Biomed Sci, 2016, 59, 125-134.
[http://dx.doi.org/10.1016/j.shpsc.2016.02.016] [PMID: 26965225]
[3]
Freed, E.O. HIV-1 assembly, release and maturation. Nat. Rev. Microbiol., 2015, 13(8), 484-496.
[http://dx.doi.org/10.1038/nrmicro3490] [PMID: 26119571]
[4]
Wikipedia. https://en.wikipedia.org/wiki/Virus
[5]
Blaas, D. Viral entry pathways: the example of common cold viruses. Wien. Med. Wochenschr., 2016, 166(7-8), 211-226.
[http://dx.doi.org/10.1007/s10354-016-0461-2] [PMID: 27174165]
[6]
Komaroff, A.L. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J.Clin.Virol., 2006,, 37(Suppl. 1), S39-S46.
[http://dx.doi.org/10.1016/S1386-6532(06)70010-5] [PMID: 17276367]
[7]
Chen, C-H.; Chiu, Y-L.; Wei, F-C.; Koong, F-J.; Liu, H-C.; Shaw, C-K.; Hwu, H.G.; Hsiao, K.J. High seroprevalence of Borna virus infection in schizophrenic patients, family members and mental health workers in Taiwan. Mol. Psychiatry, 1999, 4(1), 33-38.
[http://dx.doi.org/10.1038/sj.mp.4000484] [PMID: 10089006]
[8]
Bertoletti, A.; Gehring,, A. Immune response and tolerance during chronic hepatitis B virus infection. Hepatol. Res., 2007, 37(Suppl. 3), S331-S338.
[http://dx.doi.org/10.1111/j.1872-034X.2007.00221.x] [PMID: 17931183]
[9]
Rodrigues, C.; Deshmukh, M.; Jacob, T.; Nukala, R.; Menon, S.; Mehta, A. Significance of HBV DNA by PCR over serological markers of HBV in acute and chronic patients. Indian J. Med. Microbiol., 2001, 19(3), 141-144.
[PMID: 17664817]
[10]
Nguyen, V.T.; McLaws, M.L.; Dore, G.J. Highly endemic hepatitis B infection in rural Vietnam. J. Gastroenterol. Hepatol., 2007,, 22(12,), 2093-2100.
[http://dx.doi.org/10.1111/j.1440-1746.2007.05010.x] [PMID: 17645465]
[11]
Zhou, P.; Yang, X-L.; Wang, X.G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.R.; Zhu, Y.; Li, B.; Huang, C.L.; Chen, H.D.; Chen, J.; Luo, Y.; Guo, H.; Jiang, R.D.; Liu, M.Q.; Chen, Y.; Shen, X.R.; Wang, X.; Zheng, X.S.; Zhao, K.; Chen, Q.J.; Deng, F.; Liu, L.L.; Yan, B.; Zhan, F.X.; Wang, Y.Y.; Xiao, G.F.; Shi, Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature,, 2020,, 579(7798), 270-273.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]
[12]
Wu, F.; Zhao, S.; Yu, B.; Chen, Y.M.; Wang, W.; Song, Z.G.; Hu, Y.; Tao, Z.W.; Tian, J.H.; Pei, Y.Y.; Yuan, M.L.; Zhang, Y.L.; Dai, F.H.; Liu, Y.; Wang,, Q.M.; Zheng, J.J.; Xu, L.; Holmes, E.C.; Zhang, Y.Z. A new coronavirus associated with human respiratory disease in China. Nature, 2020, 579(7798), 265-269.
[http://dx.doi.org/10.1038/s41586-020-2008-3] [PMID: 32015508]
[13]
Andersen, K.G.; Rambaut, A.; Lipkin, W.I.; Holmes, E.C.; Garry, R.F.; Garry, R.F. The proximal origin of SARS-CoV-2. Nat. Med., 2020, 26(4), 450-452.
[http://dx.doi.org/10.1038/s41591-020-0820-9] [PMID: 32284615]
[14]
Wan, Y.; Shang, J.; Graham, R.; Baric, R.S.; Li, F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol., 2020, 94(7), :e00127.-20.
[http://dx.doi.org/10.1128/JVI.00127-20] [PMID: 31996437]
[15]
(a)Belouzard, S.; Millet, J.K.; Licitra, B.N.; Whittaker, G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses,, 2012, 4(6), 1011-1033.
[http://dx.doi.org/10.3390/v4061011] [PMID: 22816037]
(b)Walls, A.C.; Park, Y-J.; Tortorici, M.A.; Wall, A.; McGuire, A.T; Veesler, D. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 2020, 181(2), 281-292.e6.
[http://dx.doi.org/10.1016/j.cell.2020.02.058] [PMID: 32155444]
[16]
Wrapp, D.; Wang, N.; Corbett, K.S.; Goldsmith, J.A.; Hsieh, C-L.; Abiona, O.; Graham, B.S.; McLellan, J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 2020, 367(6483), 1260-1263.
[http://dx.doi.org/10.1126/science.abb2507] [PMID: 32075877]
[17]
Letko, M.; Marzi, A.; Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol., 2020, 5(4), 562-569.
[http://dx.doi.org/10.1038/s41564-020-0688-y] [PMID: 32094589]
[18]
Jia, H.P.; Look, D.C.; Shi, L.; Hickey, M.; Pewe, L.; Netland, J.; Farzan, M.; Wohlford-Lenane, C.; Perlman, S.; McCray, P.B., Jr ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol., 2005, 79(23), 14614-14621.
[http://dx.doi.org/10.1128/JVI.79.23.14614-14621.2005] [PMID: 16282461]
[19]
Ziebuhr, J.; Snijder, E.J.; Gorbalenya, A.E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol., 2000, 81(Pt 4), 853-879.
[http://dx.doi.org/10.1099/0022-1317-81-4-853] [PMID: 10725411]
[20]
Xu, X.; Liu, Y.; Weiss, S.; Arnold, E.; Sarafianos, S.G.; Ding, J. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res., 2003, 31(24), 7117-7130.
[http://dx.doi.org/10.1093/nar/gkg916] [PMID: 14654687]
[21]
Almazán, F.; Sola, I.; Zuñiga, S.; Marquez-Jurado, S.; Morales, L.; Becares, M.; Enjuanes, L. Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res., 2014,, 189, 262-270.
[http://dx.doi.org/10.1016/j.virusres.2014.05.026] [PMID: 24930446]
[22]
Alberta, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walters, P. Molecular Biology of the Cell, 4th ed; Garland Science: NewYork, London,, 2002.
[23]
Le Page, C.; Génin, P.; Baines, M.G.; Hiscott, J. Interferon activation and innate immunity. Rev.Immunogenet., 2000, 2(3), 374-386.
[PMID: 11256746]
[24]
Parkin, J.; Cohen, B. An overview of the immune system. Lancet, 2001, 357(9270), 1777-1789.
[http://dx.doi.org/10.1016/S0140-6736(00)04904-7] [PMID: 11403834]
[25]
Melief, C.J.; van Hall, T.; Arens, R.; Ossendorp, F.; van der Burg, S.H. Therapeutic cancer vaccines. J. Clin. Invest., 2015, 125(9), 3401-3412.
[http://dx.doi.org/10.1172/JCI80009] [PMID: 26214521]
[26]
Dai, X.; Xiong, Y.; Li, N.; Jian, C. Vaccine types.In:Vaccines - the History and Future; Vijay, Kumar, Ed.; IntechOpen: UK, 2019,, pp. 1-6.
[27]
Delrue, I.; Verzele, D.; Madder, A.; Nauwynck, H.J. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Expert Rev. Vaccines, 2012, 11(6), 695-719.
[http://dx.doi.org/10.1586/erv.12.38] [PMID: 22873127]
[28]
Minor, P.D. Live attenuated vaccines: Historical successes and current challenges. Virology, 2015, 479-480, 379-392.
[http://dx.doi.org/10.1016/j.virol.2015.03.032] [PMID: 25864107]
[29]
Del Rio, C.; Malani, P.N. COVID-19—New insights on a rapidly changing epidemic. JAMA, 2020, 323, 1339-1340.
[http://dx.doi.org/10.1001/jama.2020.3072] [PMID: 32108857]
[30]
Block, S.S. Disinfection; Sterilization and PreservationLippincott Williams Wilkins, 2001, p. 239.
[31]
Wikipedia. https://en.wikipedia.org/wiki/Remdesivir
[32]
Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhong, W.; Xiao, G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res., 2020, 30(3), 269-271.
[http://dx.doi.org/10.1038/s41422-020-0282-0] [PMID: 32020029]
[33]
Carradori, S. Are there any therapeutic options currently available for Wuhan coronavirus? Anti-Inflam. Anti-Allergy Agents. Med. Chem., 2020, 19, 85-87.
[34]
Bajkova, D.; Klann, K.; Koch, B.; Widera, M.; Krause, D.; Ciesek, S.; Cinatl, J.; Münch, C. SARS-CoV-2 infected host cell proteomics reveal potential therapy targets; Nature Research, 2020.
[35]
Mori, M.; Capasso, C.; Carta, F. William a Donald, W. A.; Supuran, C. T. A deadly spillover: SARS-CoV-2 outbreak; Expert Opin. Therap. Patents, 2020.
[36]
Yao, T-T.; Qian, J-D.; Zhu, W-Y.; Wang, Y.; Wang, G.Q. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option. J. Med. Virol., 2020, 92, 556-563.
[http://dx.doi.org/10.1002/jmv.25729] [PMID: 32104907]
[37]
Lin, M.H.; Moses, D.C.; Hsieh, C.H.; Cheng, S.C.; Chen, Y.H.; Sun, C.Y.; Chou, C.Y. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. Antiviral Res., 2018, 150, 155-163.
[http://dx.doi.org/10.1016/j.antiviral.2017.12.015] [PMID: 29289665]
[38]
Li, G.; De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov., 2020, 19(3), 149-150.
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]
[39]
Tian, X.; Li, C.; Huang, A.; Xia, S.; Lu, S.; Shi, Z.; Lu, L.; Jiang, S.; Yang, Z.; Wu, Y.; Ying, T. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect., 2020, 9(1), 382-385.
[http://dx.doi.org/10.1080/22221751.2020.1729069] [PMID: 32065055]

Rights & Permissions Print Cite
Article Metrics
14
© 2024 Bentham Science Publishers | Privacy Policy